Sabra Healthcare REIT Inc. (NASDAQ:SBRA) saw strong trading volume on Tuesday . 917,994 shares were traded during trading, an increase of 43% from the previous session’s volume of 643,393 shares.The stock last traded at $23.51 and had previously closed at $23.70.

A number of analysts have commented on the company. Canaccord Genuity reiterated a “hold” rating on shares of Sabra Healthcare REIT in a research report on Monday, May 2nd. SunTrust Banks Inc. upgraded Sabra Healthcare REIT from a “neutral” rating to a “buy” rating and set a $25.00 target price on the stock in a research report on Wednesday, June 1st. Zacks Investment Research upgraded Sabra Healthcare REIT from a “hold” rating to a “buy” rating and set a $23.00 target price on the stock in a research report on Tuesday, July 5th. Bank of America Corp. downgraded Sabra Healthcare REIT from a “neutral” rating to an “underperform” rating in a research report on Monday. Finally, Cantor Fitzgerald assumed coverage on Sabra Healthcare REIT in a research report on Thursday, June 23rd. They set a “buy” rating and a $28.00 target price on the stock. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and four have given a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $23.04.

The firm has a market capitalization of $1.53 billion and a PE ratio of 43.96. The company’s 50-day moving average is $21.62 and its 200-day moving average is $20.27.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Monday, May 2nd. The company reported $0.53 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.55 by $0.02. The firm earned $62.60 million during the quarter, compared to the consensus estimate of $57.50 million. During the same quarter in the previous year, the business posted $0.53 EPS. The business’s revenue for the quarter was up 12.6% compared to the same quarter last year. Equities research analysts predict that Sabra Healthcare REIT Inc. will post $2.25 EPS for the current fiscal year.

In other news, Director Milton J. Walters sold 2,000 shares of Sabra Healthcare REIT stock in a transaction on Monday, June 6th. The stock was sold at an average price of $22.04, for a total transaction of $44,080.00. Following the transaction, the director now directly owns 24,055 shares in the company, valued at approximately $530,172.20. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Several institutional investors have recently modified their holdings of SBRA. Morgan Stanley boosted its position in shares of Sabra Healthcare REIT by 0.9% in the fourth quarter. Morgan Stanley now owns 55,899 shares of the company’s stock valued at $1,131,000 after buying an additional 495 shares during the period. New York State Common Retirement Fund boosted its position in shares of Sabra Healthcare REIT by 4.7% in the fourth quarter. New York State Common Retirement Fund now owns 82,967 shares of the company’s stock valued at $1,678,000 after buying an additional 3,703 shares during the period. Rhumbline Advisers boosted its position in shares of Sabra Healthcare REIT by 4.7% in the fourth quarter. Rhumbline Advisers now owns 102,430 shares of the company’s stock valued at $2,072,000 after buying an additional 4,565 shares during the period. California Public Employees Retirement System boosted its position in shares of Sabra Healthcare REIT by 1.3% in the fourth quarter. California Public Employees Retirement System now owns 109,400 shares of the company’s stock valued at $2,213,000 after buying an additional 1,400 shares during the period. Finally, California State Teachers Retirement System boosted its position in shares of Sabra Healthcare REIT by 1.6% in the fourth quarter. California State Teachers Retirement System now owns 120,686 shares of the company’s stock valued at $2,441,000 after buying an additional 1,903 shares during the period.

Sabra Health Care REIT, Inc is a real estate investment trust. The Company owns and invests in real estate serving the healthcare industry. The Company’s segment is investments in healthcare-related real estate properties. Its primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.